Kenneth E. Rittle
10Patents
6h-index
34Co-inventors
66Inventor score
Filing activity: Nov 23, 1981 → Nov 10, 2006
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5464788A | Tocolytic oxytocin receptor antagonists | Chemistry; Metallurgy | 78 | Expired |
| US5756504A | Tocolytic oxytocin receptor antagonists | Chemistry; Metallurgy | 58 | Expired |
| US5670509A | Tocolytic oxytocin receptor antagonists | Chemistry; Metallurgy | 21 | Expired |
| US4397786A | Method of preparing statine and derivatives | Emerging Cross-Sectional Technologies | 12 | Expired |
| US4609641A | Renin-inhibitory peptide analogs | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6387893B1 | Spirotricyclic substituted azacycloalkane derivatives and uses thereof | Chemistry; Metallurgy | 8 | Expired |
| US7745452B2 | Quinazolinone T-type calcium channel antagonists | Chemistry; Metallurgy | 4 | Expired |
| US6515011B2 | Thrombin inhibitors | Human Necessities | 4 | Expired |
| US8003653B2 | Imidazolidinone compounds useful as β-secretase inhibitors for the treatment of Alzheimer's disease | Chemistry; Metallurgy | 2 | Active |
| US8114887B2 | Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.